Stella Diagnostics, Inc. (SLDX)
0.014
0.00 (0.00%)
USD |
OTCM |
Jun 09, 16:00
Price Chart
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 4.221M |
| 52 Week High (Daily) | |
| 52 Week Low (Daily) | |
| All-Time High (Daily) | |
| Year to Date Total Returns (Daily) | |
| 1 Month Total Returns (Daily) | |
| 1 Year Total Returns (Daily) | -71.43% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | |
| PS Ratio | 2.763 |
| Price to Book Value | -- |
| EV to EBITDA | |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | |
| Financials | |
| Revenue (5 Year Growth) | |
| Revenue (Quarterly YoY Growth) | |
| EPS Diluted (5 Year Growth) | |
| EPS Diluted (Quarterly YoY Growth) | |
| Debt to Equity Ratio | -0.4644 |
| Return on Equity | |
| Return on Assets | |
| Risk | |
| Beta (5Y) | |
| Max Drawdown (5Y) | 99.46% |
Profile
| Stella Diagnostics, Inc. operates as a molecular diagnostics-based organization, which focuses on improving patient management strategies. The company was founded by Fred Zaino and Joe Abdo in 1992 and is headquartered in Salt Lake City, UT. |
| URL | http://www.stelladx.com |
| Investor Relations URL | N/A |
| HQ State/Province | Utah |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Profile
| Stella Diagnostics, Inc. operates as a molecular diagnostics-based organization, which focuses on improving patient management strategies. The company was founded by Fred Zaino and Joe Abdo in 1992 and is headquartered in Salt Lake City, UT. |
| URL | http://www.stelladx.com |
| Investor Relations URL | N/A |
| HQ State/Province | Utah |
| Sector | Health Care |
| Industry | Health Care Providers & Services |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |